• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
CMS Finalizes Controversial PAMA Fee Schedule

CMS Finalizes Controversial PAMA Fee Schedule

by Glenn S. Demby | Nov 21, 2017 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

From - G2 Compliance Advisor
It's official. Brushing aside fierce lab industry opposition, CMS has decided to go forward with its PAMA Clinical Laboratory Fee Schedule (CLFS) in 2018…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Case of the Month: Lab Tests Play Key Role in $19 Million Detroit Opioid Scheme

by Glenn S. Demby | Oct 24, 2017 | Essential, Lab Compliance Advisor, News at a Glance-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

PAMA-Geddon: Proposed 2018 Lab Pay Rates Are a Bloodbath

by Glenn S. Demby | Oct 24, 2017 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
CMS Finalizes Controversial PAMA Fee Schedule

Help Your Lab Brace for Key Medicare Outpatient Reimbursement Changes

by Glenn S. Demby | Aug 7, 2017 | Brief Your CEO-lca, Essential, Lab Compliance Advisor

From - G2 Compliance Advisor
With the 2018 Clinical Laboratory Fee Schedule (CLFS) still in the works, CMS proposed changes to the Hospital Outpatient Prospective Payment System (HOPPS) rules on…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Brief Your CEO: 8 Changes in Trump Travel Ban

by Glenn S. Demby | Mar 14, 2017 | Compliance Perspectives-lca, Essential, Lab Compliance Advisor, News at a Glance-lca

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com